| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus. | Clin Cancer Res | 2013 | 3.22 |
| 2 | Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer. | Mol Ther | 2011 | 0.96 |
| 3 | Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1. | Clin Cancer Res | 2010 | 0.90 |
| 4 | Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans. | Int J Cancer | 2014 | 0.89 |
| 5 | Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures. | Eur J Cancer | 2009 | 0.80 |
| 6 | Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment. | J Transl Med | 2013 | 0.79 |